Literature DB >> 31205660

Management of benign oesophageal strictures.

Nicholas E Burr1,2, Simon M Everett1.   

Abstract

Benign oesophageal strictures are an important gastrointestinal condition that can cause substantial morbidity. There are many different aetiologies and each case needs careful evaluation and individualised treatment. Management usually involves targeting therapy to the underlying cause, but oesophageal dilatation is an important part of the algorithm. The recent British Society of Gastroenterology guidelines provide advice on the use of dilatation for benign strictures and cover patient preparation, the dilatation procedure and disease-specific considerations. This article provides a summary of the key messages from the guidelines and applies them to routine clinical practice. It also includes practical advice on the clinical assessment, investigation and management of benign oesophageal strictures and gives an approach to the management of refractory strictures. Areas where evidence is sparse and further research is needed are highlighted.

Entities:  

Keywords:  gastroesophageal reflux disease; oesophageal strictures; therapeutic endoscopy

Year:  2019        PMID: 31205660      PMCID: PMC6540277          DOI: 10.1136/flgastro-2018-101075

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  25 in total

Review 1.  Role of endoscopic clipping in the treatment of oesophageal perforations.

Authors:  György Lázár; Attila Paszt; Eszter Mán
Journal:  World J Gastrointest Endosc       Date:  2016-01-10

2.  The refractory and the recurrent esophageal stricture: a definition.

Authors:  Michael L Kochman; Steven A McClave; H Worth Boyce
Journal:  Gastrointest Endosc       Date:  2005-09       Impact factor: 9.427

Review 3.  Tools for endoscopic stricture dilation.

Authors:  Uzma D Siddiqui; Subhas Banerjee; Bradley Barth; Shailendra S Chauhan; Klaus T Gottlieb; Vani Konda; John T Maple; Faris M Murad; Patrick R Pfau; Douglas K Pleskow; Jeffrey L Tokar; Amy Wang; Sarah A Rodriguez
Journal:  Gastrointest Endosc       Date:  2013-09       Impact factor: 9.427

4.  Guideline for obtaining valid consent for gastrointestinal endoscopy procedures.

Authors:  Simon M Everett; Helen Griffiths; U Nandasoma; Katie Ayres; Graham Bell; Mike Cohen; Siwan Thomas-Gibson; Mike Thomson; Kevin M T Naylor
Journal:  Gut       Date:  2016-06-20       Impact factor: 23.059

5.  Endoscopic dilation of benign esophageal strictures: report on 1043 procedures.

Authors:  J C Pereira-Lima; R P Ramires; I Zamin; A P Cassal; C A Marroni; A A Mattos
Journal:  Am J Gastroenterol       Date:  1999-06       Impact factor: 10.864

6.  Optimal number of biopsy specimens in the diagnosis of carcinoma of the oesophagus.

Authors:  N Lal; D K Bhasin; A K Malik; N M Gupta; K Singh; S K Mehta
Journal:  Gut       Date:  1992-06       Impact factor: 23.059

7.  Natural history and management of refractory benign esophageal strictures.

Authors:  Alessandro Repici; Aaron J Small; Aaron Mendelson; Manol Jovani; Loredana Correale; Cesare Hassan; Lorenzo Ridola; Andrea Anderloni; Elisa Chiara Ferrara; Michael L Kochman
Journal:  Gastrointest Endosc       Date:  2016-01-30       Impact factor: 9.427

8.  Refractory esophageal strictures: what to do when dilation fails.

Authors:  Petra G A van Boeckel; Peter D Siersema
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

9.  Endoscopic vacuum therapy for esophageal perforations and leakages.

Authors:  Oliver Möschler; Christoph Nies; Michael K Mueller
Journal:  Endosc Int Open       Date:  2015-08-11

10.  Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines.

Authors:  Andrew M Veitch; Geoffroy Vanbiervliet; Anthony H Gershlick; Christian Boustiere; Trevor P Baglin; Lesley-Ann Smith; Franco Radaelli; Evelyn Knight; Ian M Gralnek; Cesare Hassan; Jean-Marc Dumonceau
Journal:  Gut       Date:  2016-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.